Affordable Care Act Affordable Care Act: Fills Hole in Medicare Part D Prescription Benefit Thomas Sullivan Feb 21, 2012 0 Nearly 3.6 million people with Medicare saved $2.1 billion on their prescription drugs in 2011 thanks to the Affordable Care Act…
FDA FDA Distraction Study – Shows No Distractions After All Thomas Sullivan Feb 20, 2012 0 Almost two years ago, the Food and Drug Administration (FDA) issued proposed guidance for direct to consumer television (DTC) and…
Uncategorized Physician Payment Sunshine Comments Thomas Sullivan Feb 19, 2012 0 Illionis State Medical Society Download AdvaMed Comments to CMS PPSA Download American Society for Reproductive Medicine CMS…
Open Payments Physician Payment Sunshine: Alliance for Continuing Education in the Health… Thomas Sullivan Feb 17, 2012 0 We have just hours to go before the deadline to submit comments to Centers for Medicare and Medicaid Services (CMS) on the…
Open Payments Physician Payment Sunshine: Friday Deadline Approaching and AAFP Comments… Thomas Sullivan Feb 16, 2012 0 This week marks the last week that the public can submit comments on the proposed regulations that will implement the Physician…
Uncategorized Drug Information Association: Comparative Effectiveness Conference Thomas Sullivan Feb 15, 2012 0 We have recently seen a lot of activity regarding the Patient-Centered Outcomes Research Institute (PCORI), an independent,…
Affordable Care Act Road to Reform: The Healthcare Regulatory Burden Thomas Sullivan Feb 15, 2012 0 A recent article from California Healthline looked at some of the regulatory problems our health care system is facing…
ACCME ACCME Launches New Website Thomas Sullivan Feb 14, 2012 0 The Accreditation Council for Continuing Medical Education (ACCME) announced the launch of their redesigned Web site. The…
Conflict of Interest The Difficulty and High Costs in Creating New Medications Thomas Sullivan Feb 14, 2012 0 Over the past several years, there has been significant discussion about the difficulty pharmaceutical and medical device…
Uncategorized FDA Issues Draft Guidance’s on Bio-Similars Thomas Sullivan Feb 13, 2012 0 The U.S. Food and Drug Administration (FDA) last week issued three draft guidance documents on biosimilar product development to…